Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...
Read MoreAdults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in A1C and a 30% lower rate of hypoglycaemic episodes after starting basal insulin ORLANDO, Fla. , June 23, 2018 /PRNewswire/ ...
Read MoreORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection) had a significant reduction in HbA 1c and a 30% lower rate of hypoglycaemic episodes ...
Read MoreORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Poster Presentation #1083-P Ozempic ® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, ...
Read MoreORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to ...
Read MorevFit PLUS a proven and safe at-home feminine wellness device that improves vaginal health COLORADO SPRINGS, Colo. , June 23, 2018 /PRNewswire-PRWeb/ -- Dr. John R. Burroughs , the Medical Director of Springs Aesthetics, is proud to be the ...
Read MoreINVOKANA® nearly doubled the likelihood of clinically significant weight loss compared to GLP-1s TITUSVILLE, N.J. and ORLANDO, Fla. , June 23, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today ...
Read MoreFractyl also announces one-year safety and efficacy data from the multicenter Revita-1 clinical trial of the Revita DMR system targeting the duodenal lining in patients with type 2 diabetes. LEXINGTON, Mass. and ORLANDO, Fla. , June 23, ...
Read MoreAdults with type 2 diabetes treated with Tresiba ® (insulin degludec injection) had a significant reduction in HbA 1c and a 30 per cent lower rate of hypoglycemic episodes compared with those treated with Toujeo ® (insulin glargine U300) ...
Read MoreMIAMI , June 23, 2018 /PRNewswire/ -- With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual convention, from today through June 27 in Tampa , to see ...
Read MoreAdults treated with Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 weeks ORLANDO, Fla. , June 23, ...
Read MoreBAGSVÆRD, Denmark , June 23, 2018 /PRNewswire/ -- Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy ® (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates ...
Read MoreA 63-year old English school teacher from Gariahat, Mrs. Riddhima Chatterjee (name changed), was in an acute knee pain for more than 8 years. Symptoms of knee arthritis were clear and the condition worsened gradually over years. The intensity of ...
Read MoreSRL Diagnostics, India’s largest and preferred diagnostics chain, has bagged the prestigious "Best Diagnostics Centre” award at the CNBC-TV18’s prestigious India Healthcare & Wellness Awards 2017-18 held in Mumbai. Mr Arindam Haldar, CEO, SRL ...
Read MoreWomen's Excellence in Menopause is a specialty area of the practice for women that have symptoms of menopause LAKE ORION, Mich. , June 23, 2018 /PRNewswire-PRWeb/ -- Women's Excellence's goal is treating the whole person. All of their ...
Read MoreEndometriosis is a very complicated disease process that needs a well thought out treatment plan. BIRMINGHAM , LAKE ORION , CLARKSTON , ROCHESTER and WEST BLOOMFIELD, Mich. , June 23, 2018 /PRNewswire-PRWeb/ -- Many women are confused ...
Read MoreHealth Data Decisions' CEO Michael Blumental will partner with Janine Sala, Associate Director of Clinical Quality at UnitedHealthcare, to deliver the keynote for the HEDIS® track at the 3rd Annual RISE Qualipalooza Leadership Summit on Monday, ...
Read MoreTwo Cell Signaling Technology antibody clones, ALK (D5F3®) and ROS1 (D4D6®), were featured in an article authored by the Tumor Biomarker Experts of the Chinese Society of Clinical Oncology. The article, Guidelines for diagnosis and treatment of ALK ...
Read MoreCHAPEL HILL, N.C. , June 22, 2018 /PRNewswire/ -- Pharmaceutical companies are increasingly using digital engagement channels to more effectively communicate with their customers. Unlike many other operational areas of pharma, the performance ...
Read MoreSAN FRANCISCO , June 22, 2018 /PRNewswire/ -- Eidos Therapeutics, Inc. (Nasdaq: EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis ...
Read MoreOTTAWA , June 22, 2018 /CNW/ - With the growing availability of fentanyl test strips on store shelves and online, Health Canada would like to remind Canadians of the potential limitations when using fentanyl test strips to detect fentanyl or ...
Read MoreLegislation Would Make Permanent the Authorization for NPs to Prescribe Medication Assisted Therapies AUSTIN, Texas , June 22, 2018 /PRNewswire-USNewswire/ -- The American Association of Nurse Practitioners would like to thank congressional ...
Read MoreProposal would help to protect Canadians, particularly youth, from the health hazards of tobacco products OTTAWA , June 22, 2018 /CNW/ - Despite decades of effort to reduce smoking rates and a steady decline in the percentage of Canadians ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers